European Journal of Clinical Pharmacology

, Volume 33, Issue 3, pp 337–338 | Cite as

Urinary excretion of cimetropium bromide after multiple oral doses

  • B. P. Imbimbo
  • A. Piperno
  • G. Fiorelli
  • F. Muzio
  • S. Daniotti
Letters To The Editors

Key words

anticholinergics cimetropium bromide urinary excretion drug accumulation 

References

  1. 1.
    Beerman B, Hellström K, Rosen A (1972) Gastrointestinal absorption of certain anticholinergic drugs. Eur J Clin Pharmacol 5: 87–92Google Scholar
  2. 2.
    Moller J, Rosen A (1968) Comparative studies of intramuscular and oral effective doses of some anticholinergic drugs. Acta Med Scand 184: 201–209Google Scholar
  3. 3.
    Hellström K, Rosen A, Soderlund K (1970) The gastrointestinal absorption and the excretion of H3-butyl scopolamine (hyoscine butylbromide) in man. Scand J Gastroenterol 5: 585–592Google Scholar
  4. 4.
    Beerman B, Hellström K, Rosen A (1971) The gastrointestinal absorption of anticholinergic drugs: Comparison between individuals. Acta Pharmacol Toxicol 29 [Suppl 3]: 98–102Google Scholar
  5. 5.
    Schiavone A, Schiavi GB, De Conti L, Micheletti R, Sagrada A, Hammer R, Giachetti A (1985) Cimetropium: Characterization of antimuscarinic and spasmolytic properties. Arnzeimittelforsch 35: 796–799Google Scholar
  6. 6.
    Scarpignato C, Bianchi Porro G (1985) Cimetropium bromide, a new antispasmodic compound: Pharmacology and therapeutic perspectives. Int J Clin Pharm Res 5: 467–477Google Scholar
  7. 7.
    Imbimbo BP, Daniotti S, Vidi A, Foschi D, Saporiti F, Ferrante L (1986) Discontinuous oral absorption and cimetropium bromide, a new antispasmodic drug. J Pharm Sci 75: 680–684Google Scholar
  8. 8.
    Colburn WA (1983) Estimating the accumulation of drugs. J Pharm Sci 72: 833–834Google Scholar
  9. 9.
    Albano VMO, Centonze V, Campanozzi F, Attolini E, Macinagrossa G, Imbimbo BP, Muzio F (1987) Oral cimetropium bromide (CB), a new antimuscarinic drug, for long term treatment of irritable bowel syndrome. Gastroenterology 92: 1292Google Scholar
  10. 10.
    Valentini M, Piazzi L, Imbimbo BP, Dobrilla G (1986) Efficacy of cimetropii bromidum for long term treatment of irritable bowel syndrome (IBS). Gastro-Entero-Hepatologie 4: 37Google Scholar
  11. 11.
    Passaretti S, Imbimbo BP, Tittobello A (1987) Effects of oral cimetropium bromide (CB) on intestinal transit time in irritable bowel syndrome patients. Gastroenterology 92: 1567Google Scholar
  12. 12.
    Bassotti G, Imbimbo BP, Gaburri M, Daniotti S, Morelli A (1987) Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide. Digestion 37: 59–64Google Scholar
  13. 13.
    Lanfranchi GA, Bazzocchi G, Fois F, Imbimbo BP (1986) Cimetropium bromide reduces the colonic motor response to eating in patients with irritable bowel syndrome. Dig Dis Sci 31: 319SGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • B. P. Imbimbo
    • 1
  • A. Piperno
    • 2
  • G. Fiorelli
    • 2
  • F. Muzio
    • 1
  • S. Daniotti
    • 1
  1. 1.Medical DepartmentInstituto De Angeli S.p.A.MilanItaly
  2. 2.Internal MedicineUniversity of MilanMilanItaly

Personalised recommendations